Home

14159 capital (GP), LLC

CIK 1317493 · last filed 2012-03-14

14159 capital (GP), LLC is a corporate insider who has filed 59 SEC Form 4 insider transactions across 13 companies since 2007. The most recent filing shows the insider bought $243.5K of TZYM on Mar 14, 2012. Across all open-market trades the lifetime net is +$6.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $43.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$43.95M

Companies

13

Total Filings

59

Lifetime Open-Market Net

$6.15M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Ocera Therapeutics, Inc. (TZYM) Delisted 10%+ Owner 4,609 — — $243.5K 1 2012-03-14
GENOMIC HEALTH INC (GHDX) Delisted Director 215,669 — — $4.35M 15 2012-02-29
INCY Director 344,064 $117.67 $40.49M -$303.0K 12 2012-01-17
Seagen Inc. (SGEN) Delisted Director 323,148 $228.74 $73.92M $2.01M 5 2011-09-08
AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted 10%+ Owner 143,568 — — -$430.3K 3 2011-08-03
Ardea Biosciences, Inc./DE (RDEA) Delisted Director 93,282 — — $801.3K 2 2011-01-24
RPRX 10%+ Owner 38,386 $58.83 $2.26M $49.1K 1 2010-04-28
BCRX 10%+ Owner 128,783 $9.34 $1.20M -$200.9K 1 2009-06-01
VIROPHARMA INC (VPHM) Delisted 10%+ Owner 187,491 — — -$467.3K 4 2009-05-26
Aceragen, Inc. (IDRA) Delisted 10%+ Owner 928 $7.22 $6.7K -$112.9K 2 2008-07-21
ALLOS THERAPEUTICS INC (ALTH) Delisted 10%+ Owner 264,699 — — $309.2K 3 2008-05-27
TAPESTRY PHARMACEUTICALS, INC (TPPH) Delisted 10%+ Owner 112,451 — — -$473 1 2008-04-08
Aceragen, Inc. (IDP) Delisted 10%+ Owner 31,708 — — -$101.7K 3 2007-12-07

Recent Filings

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2012-03-14 Ocera Therapeutics, Inc. (TZYM) Delisted Buy (P) +95,646 $243.5K EDGAR
2012-02-29 GENOMIC HEALTH INC (GHDX) Delisted Buy (P) +19,428 $564.7K EDGAR
2012-02-16 GENOMIC HEALTH INC (GHDX) Delisted Buy (P) +21,639 $635.4K EDGAR
2012-01-23 — Mixed +37,341 $614.9K
2012-01-17 INCY Buy (P) +43,875 $718.2K EDGAR
2011-12-05 GENOMIC HEALTH INC (GHDX) Delisted Buy (P) +9,456 $265.9K EDGAR
2011-11-23 — Buy (P) +21,051 $263.1K
2011-11-14 GENOMIC HEALTH INC (GHDX) Delisted Buy (P) +30,318 $825.4K EDGAR
2011-11-07 GENOMIC HEALTH INC (GHDX) Delisted Buy (P) +26,541 $688.5K EDGAR
2011-10-04 — Buy (P) +9,330 $108.2K
Showing 1–10 of 59
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.